Sign in

CIK 0001724521 · Large accelerated filer

Arcus Biosciences, Inc.

Sign in to watch
Ticker
RCUS
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
473898435
Phone
(510) 694-6200
Business address
3928 POINT EDEN WAY, HAYWARD, CA, 94545
  1. 4 Shares withheld for taxes General Counsel gave up 4,182 shares (to pay taxes)
  2. 4 Grant or award Director acquired 8,400 shares (grant or award)
  3. 4 Grant or award Director acquired 8,400 shares (grant or award)
  4. 4 Grant or award Director acquired 8,400 shares (grant or award)
  5. 4 Grant or award Director acquired 8,400 shares (grant or award)
  6. 4 Grant or award Director acquired 8,400 shares (grant or award)
  7. 4 Grant or award Director acquired 8,400 shares (grant or award)
  8. 4 Grant or award Director acquired 8,400 shares (grant or award)
  9. 4 Planned sale Chief Operating Officer sold 11,551 shares at $17.55 ($202,720)
  10. 4 Planned sale Chief Operating Officer sold 13,449 shares at an average $17.92 ($240,941)
  11. 4 Planned sale Chief Operating Officer sold 58,625 shares at an average $20.09 ($1,177,967)
  12. 4 Planned sale President sold 27,032 shares at an average $20.09 ($543,187)
  13. 4/A Grant or award Chief Financial Officer acquired 22,000 shares (grant or award)
  14. 3 Insider Initial Statement of Ownership
  15. 4 Open-market buy 10% owner bought 15,238,095 shares at $21.00 ($319,999,995)
  16. 4 Grant or award Chief Financial Officer acquired 21,300 shares (grant or award)
  17. 4 Grant or award President acquired 40,000 shares (grant or award)
  18. 4 Grant or award Chief Accounting Officer acquired 8,850 shares (grant or award)
  19. 4 Grant or award General Counsel acquired 26,700 shares (grant or award)
  20. 4 Grant or award Chief Executive Officer acquired 100,000 shares (grant or award)

Page 5 of 15 · 290 filings